Deakin University
Browse

File(s) under permanent embargo

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

journal contribution
posted on 2021-09-01, 00:00 authored by Feby SaviraFeby Savira, B H Wang, A R Kompa, Z Ademi, A J Owen, S Zoungas, A Tonkin, D Liew, E Zomer
Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

History

Journal

European Journal of Preventive Cardiology

Volume

28

Issue

9

Pagination

975 - 982

Publisher

Oxford University Press

Location

Oxford, Eng.

Publisher DOI

ISSN

2047-4873

eISSN

2047-4881

Language

eng

Author URL

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Read the peer-reviewed publication

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective
Research PublicationsResearch Publications

Categories

Keywords

Cardiac & Cardiovascular SystemsCardiovascular System & Cardiologycost-effectivenessDapagliflozinheart failurehospitalisationincremental cost-effectiveness ratioLife Sciences & BiomedicineScience & TechnologyTYPE-2 DIABETES-MELLITUS

Licence

All Rights Reserved

Exports